CME Group
CME
276.01
+4.86
+1.79%
CME Group
US · CME
#171 by market cap
Listed 2002
+1.79%
276.01
+4.86
+1.79%
Collector offline (last heartbeat: 313978s ago)
· 2026-09-18 20:01
Pre-market
272.44
+0.48%
After-hours
276.01
0.00%
Overnight
271.50
+0.13%
- Market cap
- 99.25B
- P/E (TTM)i
- 23.41
- P/Bi
- 3.74
- EPSi
- 11.16
- Div yieldi
- 4.08%
- 52W posi
- 58%
Reader sentiment
Are you bullish or bearish on CME?
Anonymous reader poll. Unscientific, not investment advice.
Revenue annual, last 8 years
Latest year +6.37% YoY
Margins
- Gross margin
- 86.09%
- Operating margin
- 64.86%
- Net margin
- 61.67%
Key ratios & quality
- PEG ratioi
- 1.58
- Altman Z-Scorei
- 0.53
PEG uses trailing P/E against the 3-year net income growth rate (14.81%/yr) since forward earnings estimates aren't available here, so this is not a "forward PEG." Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
✦ Quant Financial Health how this is computed
Weak
- Altman Z-Score is 0.53, below the 1.8 "distress zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 4.31B | 4.87B | 4.88B | 4.69B | 5.02B | 5.58B | 6.13B | 6.52B |
| Gross profit | 3.64B | 3.97B | 4.03B | 3.85B | 4.27B | 4.75B | 5.28B | 5.61B |
| Selling & admin expenses | 166.10M | 174.10M | 191.30M | 151.70M | 137.40M | 144.40M | 132.70M | 150.50M |
| Research & development | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating profit | 2.61B | 2.59B | 2.64B | 2.65B | 3.02B | 3.44B | 3.93B | 4.23B |
| Pretax profit | 2.78B | 2.69B | 2.72B | 3.37B | 3.49B | 4.15B | 4.54B | 5.33B |
| Tax | 814.10M | 573.80M | 615.70M | 736.70M | 799.30M | 927.40M | 1.02B | 1.26B |
| Net profit | 1.96B | 2.12B | 2.11B | 2.64B | 2.69B | 3.23B | 3.53B | 4.07B |
| Basic EPS | 6 | 6 | 6 | 7 | 7 | 9 | 10 | 11 |
| Diluted EPS | 5.71 | 5.91 | 5.87 | 7.29 | 7.40 | 8.86 | 9.67 | 11.16 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 1.64B | 1.69B | 1.54B | 1.65B | 1.88B | 1.71B |
| Gross profit | 1.44B | 1.47B | 1.30B | 1.41B | 1.66B | 1.47B |
| Selling & admin expenses | 28.50M | 37.40M | 36.70M | 47.90M | 28.20M | 29.10M |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | 1.11B | 1.13B | 972.60M | 1.02B | 1.31B | 1.11B |
| Pretax profit | 1.24B | 1.33B | 1.18B | 1.58B | 1.51B | 1.33B |
| Tax | 288.60M | 305.20M | 269.00M | 395.50M | 356.60M | 285.90M |
| Net profit | 956.20M | 1.03B | 908.00M | 1.18B | 1.15B | 1.04B |
| Basic EPS | 3 | 3 | 2 | 3 | 3 | 3 |
| Diluted EPS | 2.62 | 2.81 | 2.49 | 3.24 | 3.18 | 2.88 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 41.89B | 39.57B | 89.28B | 161.76B | 139.08B | 94.89B | 103.03B | 165.36B |
| Cash & ST investments | 1.45B | 1.63B | 1.73B | 2.95B | 2.82B | 3.02B | 3.01B | 4.54B |
| Inventory | -- | -- | -- | -- | -- | -- | -- | -- |
| Total assets | 77.48B | 75.22B | 124.66B | 196.78B | 174.18B | 129.71B | 137.45B | 198.42B |
| Total current liabilities | 41.27B | 38.52B | 88.20B | 160.40B | 137.69B | 93.42B | 102.31B | 160.30B |
| Short-term debt | 574.20M | -- | -- | 749.40M | 16.00M | -- | 749.80M | -- |
| Long-term debt | 3.83B | 3.74B | 3.44B | 2.70B | 3.42B | 3.43B | 2.68B | 3.42B |
| Total liabilities | 51,510,400,000.00 | 49,056,000,000.00 | 98,308,100,000.00 | 169,381,000,000.00 | 147,297,000,000.00 | 102,968,200,000.00 | 110,960,100,000.00 | 169,696,000,000.00 |
| Total equity | 25.97B | 26.16B | 26.35B | 27.40B | 26.88B | 26.74B | 26.49B | 28.73B |
| Retained earnings | 4.86B | 5.01B | 5.00B | 5.15B | 4.75B | 4.46B | 4.19B | 6.43B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 123.45B | 145.45B | 152.80B | 165.36B | 169.00B | 161.63B |
| Cash & ST investments | 1.52B | 2.10B | 2.57B | 4.54B | 2.52B | 2.28B |
| Inventory | -- | -- | -- | -- | -- | -- |
| Total assets | 157.83B | 179.91B | 187.14B | 198.42B | 201.99B | 194.68B |
| Total current liabilities | 121.42B | 142.79B | 149.59B | 160.30B | 166.00B | 158.72B |
| Short-term debt | -- | -- | -- | -- | -- | -- |
| Long-term debt | 3.42B | 3.42B | 3.42B | 3.42B | 3.42B | 3.42B |
| Total liabilities | 130,800,900,000.00 | 152,168,000,000.00 | 158,954,300,000.00 | 169,696,000,000.00 | 175,375,300,000.00 | 168,156,200,000.00 |
| Total equity | 27.03B | 27.74B | 28.19B | 28.73B | 26.62B | 26.52B |
| Retained earnings | 4.69B | 5.25B | 5.71B | 6.43B | 4.88B | 5.46B |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 2.44B | 2.67B | 2.72B | 2.40B | 3.06B | 3.45B | 3.69B | 4.28B |
| Depreciation & amortization | 248.70M | 473.30M | 464.40M | 385.40M | 362.60M | 352.60M | 336.80M | 330.90M |
| Free cash flow | 2.32B | 2.43B | 2.52B | 2.28B | 2.97B | 3.38B | 3.60B | 4.19B |
| Dividends paid | -2.15B | -1.70B | -2.11B | -2.19B | -2.63B | -3.24B | -3.58B | -3.93B |
| Stock buybacks / issuance | -- | -- | -- | -- | -- | 0 | 0 | -266.10M |
| Ending cash balance | 1.38B | 38.63B | 88.42B | 160.79B | 137.97B | 93.11B | 101.79B | 164.08B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | 1.12B | 1.06B | 968.10M | 1.13B | 1.26B | 947.10M |
| Depreciation & amortization | 82.50M | 83.40M | 82.60M | 82.40M | 83.30M | 84.20M |
| Free cash flow | 1.10B | 1.04B | 949.70M | 1.10B | 1.24B | 923.50M |
| Dividends paid | -2.57B | -455.30M | -455.30M | -455.00M | -2.70B | -468.10M |
| Stock buybacks / issuance | 0 | -8.20M | 0 | -257.90M | -538.70M | -698.20M |
| Ending cash balance | 122.11B | 144.15B | 151.49B | 164.08B | 167.43B | 160.26B |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 8.12 | 8.13 | 8.03 | 9.74 | 9.79 | 11.88 | 13.08 | 14.56 |
| ROA %i | 2.56 | 2.77 | 2.11 | 1.63 | 1.43 | 2.10 | 2.61 | 2.39 |
| ROIC %i | 7.47 | 7.57 | 7.49 | 8.96 | 9.10 | 10.95 | 11.86 | 13.55 |
| 5-year avg ROE %i | 9.20 | 9.76 | 10.16 | 10.61 | 8.76 | 9.52 | 10.51 | 11.81 |
| EBIT margin %i | 68.12 | 58.91 | 59.14 | 75.50 | 72.78 | 77.31 | 76.71 | 84.41 |
| FCF / sales %i | 53.93 | 49.86 | 51.56 | 48.51 | 59.10 | 60.54 | 58.67 | 64.31 |
| Current ratioi | 1.01 | 1.03 | 1.01 | 1.01 | 1.01 | 1.02 | 1.01 | 1.03 |
| Quick ratioi | 0.05 | 0.06 | 0.02 | 0.02 | 0.02 | 0.04 | 0.03 | 0.03 |
| Debt / assetsi | 16.98 | 14.33 | 13.08 | 12.57 | 12.79 | 12.81 | 12.94 | 11.91 |
| LT debt / equityi | 14.76 | 14.33 | 13.08 | 9.84 | 12.73 | 12.81 | 10.11 | 11.91 |
| Interest coveragei | 18.61 | 16.11 | 17.38 | 21.21 | 22.45 | 27.06 | 29.22 | 31.74 |
| Revenue CAGR (3Y) %i | 9.01 | 10.63 | 10.25 | 2.86 | 1.03 | 4.54 | 9.34 | 9.11 |
| Net income CAGR (3Y) %i | 16.31 | 11.32 | -19.68 | 10.35 | 8.33 | 15.29 | 10.17 | 14.81 |
| FCF CAGR (3Y) %i | 17.90 | 13.96 | 14.69 | -0.71 | 6.91 | 10.28 | 16.49 | 12.23 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | 13.22 | 13.44 | 13.18 | 14.56 | 15.82 | 15.72 |
| ROA %i | 2.47 | 2.45 | 2.29 | 2.39 | 2.36 | 2.28 |
| ROIC %i | 12.30 | 12.53 | 12.32 | 13.55 | 14.48 | 14.40 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 76.94 | 77.83 | 78.46 | 84.41 | 85.40 | 85.18 |
| FCF / sales %i | 60.88 | 63.74 | 63.84 | 64.31 | 64.06 | 62.20 |
| Current ratioi | 1.02 | 1.02 | 1.02 | 1.03 | 1.02 | 1.02 |
| Quick ratioi | 0.02 | 0.02 | 0.02 | 0.03 | 0.02 | 0.02 |
| Debt / assetsi | 12.65 | 12.33 | 12.14 | 11.91 | 12.86 | 12.91 |
| LT debt / equityi | 12.65 | 12.33 | 12.14 | 11.91 | 12.86 | 12.91 |
| Interest coveragei | 29.72 | 30.10 | 29.45 | 31.74 | 32.93 | 32.98 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
Revenue breakdown most recent period
Business
Interest rates25.38%
Equity indexes18.99%
Market data and information services13.95%
Energy10.96%
Agricultural commodities10.77%
Metals4.50%
Other3.41%
Foreign exchange2.92%
BrokerTec fixed income2.35%
Quote time 2026-09-18 20:01:04 · For reference only, not investment advice.